organization · Reporting owner
G1 EXECUTION SERVICES, LLC
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IG Acquisition Corp.IGAC · Entity 11568 | 10% owner | October 04, 2022 | October 11, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IG Acquisition Corp.
Report date October 04, 2022 · Filed October 11, 2022
Jointly reported with SUSQUEHANNA SECURITIES, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 396,779 |
Reported balance
Holding disclosure · report date 2022-10-04 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 396,779 F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Class A Common StockSEC Table I · non-derivative | Direct | 55,662 |
Reported balance
Holding disclosure · report date 2022-10-04 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 55,662 F2: These securities are directly owned by G1 Execution Services, LLC. |
| Class A Common StockSEC Table I · non-derivative | Direct | 716 |
Reported balance
Holding disclosure · report date 2022-10-04 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 716 F2: These securities are directly owned by G1 Execution Services, LLC. F3: The reported securities are included within Units held by the reporting person. Each Unit consists of one share of Class A Common Stock and one-half of one warrant to purchase Class A Common Stock. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: These warrants are not presently exercisable and will not become exercisable until the 30th day after the completion of the issuer's business combination. F5: These warrants will expire five years after the completion of the issuer's initial business combination or earlier upon redemption or liquidation of the issuer. F2: These securities are directly owned by G1 Execution Services, LLC. |
| Warrants (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.50 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F4: These warrants are not presently exercisable and will not become exercisable until the 30th day after the completion of the issuer's business combination. F5: These warrants will expire five years after the completion of the issuer's initial business combination or earlier upon redemption or liquidation of the issuer. F2: These securities are directly owned by G1 Execution Services, LLC. F3: The reported securities are included within Units held by the reporting person. Each Unit consists of one share of Class A Common Stock and one-half of one warrant to purchase Class A Common Stock. |
| Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2023-01-20 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F6: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2023-01-20 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance Not disclosed F6: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2023-04-21 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance Not disclosed F6: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (right to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2022-10-21 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance Not disclosed F6: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (right to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2023-01-20 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-10-04 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance Not disclosed F6: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are directly owned by Susquehanna Securities, LLC.
F2: These securities are directly owned by G1 Execution Services, LLC.
F3: The reported securities are included within Units held by the reporting person. Each Unit consists of one share of Class A Common Stock and one-half of one warrant to purchase Class A Common Stock.
F4: These warrants are not presently exercisable and will not become exercisable until the 30th day after the completion of the issuer's business combination.
F5: These warrants will expire five years after the completion of the issuer's initial business combination or earlier upon redemption or liquidation of the issuer.
F6: These options are exercisable at any time prior to their expiration.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ACHILLION PHARMACEUTICALS INC
Report date January 28, 2020 · Filed January 30, 2020
Jointly reported with SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, SUSQUEHANNA SECURITIES, LLC
Section 16 reporting ended · disclosed 2020-01-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-01-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-01-28 · Other · Disposed 10,917 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F2: These securities are directly owned by G1 Execution Services, LLC ("G1X"). F4: G1X, Susquehanna Fundamental Investments, LLC ("SFNDI") and SS are affiliated entities under common ownership. G1X, SFNDI and SS each disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-01-28 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-01-28 · Other · Disposed 14,115,498 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F3: These securities are directly owned by Susquehanna Securities, LLC ("SS"). F4: G1X, Susquehanna Fundamental Investments, LLC ("SFNDI") and SS are affiliated entities under common ownership. G1X, SFNDI and SS each disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471.
F2: These securities are directly owned by G1 Execution Services, LLC ("G1X").
F3: These securities are directly owned by Susquehanna Securities, LLC ("SS").
F4: G1X, Susquehanna Fundamental Investments, LLC ("SFNDI") and SS are affiliated entities under common ownership. G1X, SFNDI and SS each disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Nuburu, Inc.
Report date January 20, 2023 · Filed January 24, 2023
Jointly reported with SUSQUEHANNA SECURITIES, LLC, CAPITAL VENTURES INTERNATIONAL
Section 16 reporting ended · disclosed 2023-01-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 91,569 |
Last balance in matching sequence
After 2023-01-20 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2023-01-20 · Other · Disposed 372,500 · Balance 71,069 F1: These securities are directly owned by Susquehanna Securities, LLC. Row 2 · 2023-01-20 · Other · Acquired 300 · Balance 71,369 F1: These securities are directly owned by Susquehanna Securities, LLC. Row 3 · 2023-01-20 · Other · Acquired 20,200 · Balance 91,569 F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (right to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2023-01-20 | Direct | 0 |
Reported balance
After 2023-01-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-20 · Other · Disposed 3,725 · Balance 0 F2: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Call Option (obligation to sell)SEC Table II · derivative / convertible security · Conversion / exercise price $12.50 · Expires 2023-01-20 | Direct | 0 |
Reported balance
After 2023-01-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-01-20 · Other · Disposed 10 · Balance 0 F2: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2023-01-20 | Direct | 44 |
Reported balance
After 2023-01-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-01-20 · Other · Disposed 3 · Balance 44 F2: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.50 · Expires 2023-01-20 | Direct | 0 |
Reported balance
After 2023-01-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-01-20 · Other · Disposed 44 · Balance 0 F2: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
| Put Option (obligation to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.50 · Expires 2023-01-20 | Direct | 0 |
Reported balance
After 2023-01-20 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-01-20 · Other · Disposed 202 · Balance 0 F2: These options are exercisable at any time prior to their expiration. F1: These securities are directly owned by Susquehanna Securities, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are directly owned by Susquehanna Securities, LLC.
F2: These options are exercisable at any time prior to their expiration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (obligation to buy) · Derivative | 202 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · derivative · entry 8 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 20,200 shares Expires 2023-01-20 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (obligation to buy) · Derivative | 44 | $0.00 Strike: $7.50 | $0.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · derivative · entry 7 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,400 shares Expires 2023-01-20 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (obligation to buy) · Derivative | 3 | $0.00 Strike: $7.50 | $0.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · derivative · entry 6 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44 Underlying: Class A Common Stock · 300 shares Expires 2023-01-20 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherCall Option (obligation to sell) · Derivative | 10 | $0.00 Strike: $12.50 | $0.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · derivative · entry 5 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires 2023-01-20 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (right to sell) · Derivative | 3,725 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · derivative · entry 4 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 372,500 shares Expires 2023-01-20 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherClass A Common Stock | 20,200 | $12.50 | $252,500.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · nonDerivative · entry 3 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,569 F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherClass A Common Stock | 300 | $7.50 | $2,250.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · nonDerivative · entry 2 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,369 F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 20, 2023 Filed Jan 24, 2023 21:26 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherClass A Common Stock | 372,500 | $10.00 | $3,725,000.00 |
DisclosureSEC source: 0001104659-23-006210 · tm234250-1_4seq1.xml · nonDerivative · entry 1 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,069 F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| October 21, 2022 Filed Oct 25, 2022 20:28 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (obligation to buy) · Derivative | 10 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-22-111192 · tm2228829-1_4seq1.xml · derivative · entry 1 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,000 shares Expires 2022-10-21 F1 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F2 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherCall Option (obligation to sell) · Derivative | 15 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · derivative · entry 6 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,500 shares Expires 2022-09-16 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherCall Option (obligation to sell) · Derivative | 16 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · derivative · entry 5 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15 Underlying: Class A Common Stock · 1,600 shares Expires 2022-09-16 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherPut Option (obligation to buy) · Derivative | 5 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · derivative · entry 4 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 500 shares Expires 2022-09-16 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherCall Option (obligation to sell) · Derivative | 85 | $0.00 Strike: $7.50 | $0.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · derivative · entry 3 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 8,500 shares Expires 2022-09-16 F2 · derivative.exercise_date: These options are exercisable at any time prior to their expiration. F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherClass A Common Stock | 1,600 | $10.00 | $16,000.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · nonDerivative · entry 2 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 443,569 F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 18:40 UTC | Nuburu, Inc. TWND · Entity 7846 | OtherClass A Common Stock | 8,500 | $7.50 | $63,750.00 |
DisclosureSEC source: 0001104659-22-101488 · tm2226225-1_4seq1.xml · nonDerivative · entry 1 SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner CAPITAL VENTURES INTERNATIONAL · CIK 0001011712 · 10% owner G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 445,169 F1 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 17:15 UTC | ACHILLION PHARMACEUTICALS INC ACHN · Entity 12234 | OtherCommon Stock | 14,115,498 | $6.30 | $88,927,637.40 |
DisclosureSEC source: 0001104659-20-008815 · a4.xml · nonDerivative · entry 2 G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC · CIK 0001446179 · 10% owner SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F1 · price: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F3 · ownership.direct: These securities are directly owned by Susquehanna Securities, LLC ("SS"). F4 · ownership.direct: G1X, Susquehanna Fundamental Investments, LLC ("SFNDI") and SS are affiliated entities under common ownership. G1X, SFNDI and SS each disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 17:15 UTC | ACHILLION PHARMACEUTICALS INC ACHN · Entity 12234 | OtherCommon Stock | 10,917 | $6.30 | $68,777.10 |
DisclosureSEC source: 0001104659-20-008815 · a4.xml · nonDerivative · entry 1 G1 EXECUTION SERVICES, LLC · CIK 0001136305 · 10% owner SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC · CIK 0001446179 · 10% owner SUSQUEHANNA SECURITIES, LLC · CIK 0001446580 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F1 · price: Disposed of pursuant to an Agreement and Plan of Merger among Achillion Pharmaceuticals, Inc., Alexion Pharmaceuticals, Inc. and Beagle Merger Sub, Inc. In addition to the cash consideration of $6.30 per share, each shareholder will also receive one contingent value right ("CVR") per share. Each CVR represents the right to receive contingent cash payments of $1.00 upon the achievement of a certain clinical trial milestone with respect to ACH-5228 and $1.00 upon the achievement of a certain regulatory approval milestone with respect to ACH-4471. F2 · ownership.direct: These securities are directly owned by G1 Execution Services, LLC ("G1X"). F4 · ownership.direct: G1X, Susquehanna Fundamental Investments, LLC ("SFNDI") and SS are affiliated entities under common ownership. G1X, SFNDI and SS each disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein, and this report shall not be deemed an admission that any of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.